This is a story about Baby Noah - he was born at just 23 weeks 3 days and weighed only 1 lb 4 oz before he benefited from Prolacta Bioscience and an exclusive human milk diet. 

Noah is my second child. My first son, Derek, was born 5 years ago at 32 weeks’ gestation. When I became pregnant with Noah, I was considered high-risk from the beginning and was placed on progesterone injections starting at 16 weeks of pregnancy. Other than having what I thought was ligament pain and the occasional Braxton Hicks contractions, I had no alarming symptoms — that is, until I began premature labor and bleeding at 22 weeks and 5 days.

[Read more…]

Why Choose Prolacta?

We are making the difference in the lives of premature infants.

Prolacta Bioscience, Inc. (Prolacta) is the pioneer in standardized human milk-based nutritional products for premature infants in the neonatal intensive care unit (NICU). Prolacta believes that there is no adequate replacement for human breast milk and, as such, we believe infant nutritional products should be human milk-based. As a privately held, for-profit and scientifically driven company, committed to improving premature infant nutrition, we are using human milk to change the standard of care in the NICU. Mothers who have a surplus of breast milk can help save the country’s most fragile infants by donating their extra breast milk through one of Prolacta’s affiliate milk banks.